| Date |
Event |
Presentation |
Speakers |
|
August 21, 2016
|
International Congress of Immunology 2016
|
International Congress of Immunology 2016
|
Alexander Y. Rudensky
|
|
September 2, 2014
|
Frontiers of Immunology in Health and Diseases
|
Frontiers of Immunology in Health and Diseases
|
Alexander Y. Rudensky
|
|
April 28, 2014
|
Companion Diagnostics: From Biomarker Identification to Market Entry
|
The Future of Academic Research towards Translation for Personalized Medicine
|
Charles L Sawyers
|
|
April 6, 2013
|
AACR Annual Meetings
|
CANCER EVOLUTION AND RESISTANCE
|
Neal Rosen
|
|
|
|
Cross-Species Analysis of Mouse and Human Cancer Chairperson: David J. Adams, Wellcome Trust Sanger Institute, Cambridge, United Kingdom
|
Hans-Guido Wendel
|
|
|
|
Building on the Success of CTLA-4 Blockade Through Biomarker Analyses and Development of Novel Combinatorial Strategies Chairperson: Jedd D. Wolchok, Memorial Sloan-Kettering Cancer Center, New York, NY
|
Jedd D. Wolchok, Margaret Callahan
|
|
|
|
Use of Next-Generation Sequencing: Implementation of Clinical Genomics Chairperson: David B. Solit, Memorial Sloan-Kettering Cancer Center, New York, NY
|
David B. Solit
|
|
|
|
Structural Aberrations in a Thousand Tumors Chairperson: Raju Kucherlapati, Harvard Medical School, Boston, MA
|
Chris Sander
|
|
|
|
The Molecular Basis for Improvement in Endometrial Cancer Therapy Co-Chairpersons: Cheryl Lyn Walker, Texas A&M University Health Science Center, Houston, TX, and Douglas A. Levine, Memorial Sloan-Kettering Cancer Center, New York, NY
|
Douglas A. Levine
|
|
|
|
Using Genomics to Guide Cancer Immunotherapy Chairperson: Robert D. Schreiber, Washington University School of Medicine, St. Louis, MO
|
James P Allison
|
|
|
|
Novel Therapeutic Concepts with Kinases, Immuno-, and Radiotherapy Chairperson: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY
|
James A. Fagin
|
|
|
|
Predictive Modeling of Cancer Treatment in Single Patients (N of 1) Moderator: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY
|
David B. Solit
|
|
|
|
Clinical Trials Based on Mutations versus Histology
|
Charles L Sawyers
|
|
|
|
Credentialing Response Biomarkers for Signal Transduction Inhibitors Chairperson: Neal Rosen, Memorial Sloan-Kettering Cancer Center, New York, NY
|
Neal Rosen
|
|
|
|
Noncoding RNAs in Cancer: From Pathogenesis to Therapeutics Chairperson: Elsa R. Flores, The University of Texas MD Anderson Cancer Center, Houston, TX
|
Andrea Ventura
|
|
|
|
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY
|
David C Lyden
|
|
|
|
Progress in Targeting Chromatin Modifying Enzymes in Cancer Therapy Victoria M. Richon, Sanofi Oncology, Cambridge, MA
|
Victoria M. Richon
|
|
|
|
Macrophages as a Therapeutic Target in the Tumor Microenvironment Johanna A. Joyce, Memorial Sloan-Kettering Cancer Center, New York, NY
|
Johanna A. Joyce
|
|
December 2, 2012
|
Tumor Immunology: Multidisciplinary Science Driving Basic and Clinical Advances
|
Session 4: Checkpoint Pathways Regulating Immune Responses to Cancer
|
James P Allison
|
|
April 14, 2011
|
Microbiota and Mucosal Immunology: The Interface in Health and Disease
|
Antibiotics and mucosal innate immune defense against bacterial infection
|
Eric Pamer
|
|
February 26, 2011
|
Mucosal Biology: A Fine Balance between Tolerance and Immunity (X5)
|
Bacterial Flagellin Stimulates TLR5-Dependent Defense Against Vancomycin-Resistant Enterococcus Infection
|
Melissa Kinnebrew
|
|
January 9, 2011
|
NK and NKT Cell Biology: Specificity and Redundancy of Innate Responses (A4)
|
The Transcription Factor PLZF Controls the Development of Mouse and Human Innate T cells | Colorado Ballroom
|
Derek Sant'Angelo
|
|
November 30, 2010
|
Tumor Immunology in Conjunction with the Cancer Immunology Working Group of the AACR
|
Clinical and correlative immunologic results of CTLA-4 blockade in melanoma
|
Jedd D. Wolchok
|
|
November 30, 2010
|
Tumor Immunology: Basic and Clinical Advances in Conjunction with the Cancer Immunology Working Group of the AACR
|
Clinical and correlative immunologic results of CTLA-4 blockade in melanoma
|
Jedd D. Wolchok
|
|
November 7, 2010
|
Frontiers of Immunology in Health and Diseases
|
Frontiers of Immunology in Health and Diseases
|
Eric Pamer
|
|
May 30, 2008
|
ASCO Annual'08 Meeting
|
general oncology sessions-- The Growing Challenge of CNS Metastases: New Therapeutic Approaches
|
Lauren E. Abrey
|
|
|
|
general oncology sessions-- Integrating the Humanistic and Scientific Aspects of Patient Care: The Perspective of Seasoned Surgical, Medical, Pediatric, and Radiation Oncologists
|
Teresa Gilewski
|
|
|
|
breast cancer-- Chemotherapy-Induced Cognitive Impairment (M06)
|
Tim A Ahles
|
|
|
|
central nervous system tumors-- Chemotherapy-Induced Cognitive Impairment (M06)
|
Tim A Ahles
|
|
|
|
central nervous system tumors-- The Growing Challenge of CNS Metastases: New Therapeutic Approaches
|
Lauren E. Abrey
|
|
|
|
clinical trials-- Patient-Reported Outcomes in Oncology
|
Ethan M. Basch
|
|
|
|
gynecologic cancer-- Benefit of Multimodality Management of Advanced Sarcoma: Why the Medical Oncologist Should Not Work Alone
|
Murray F. Brennan
|
|
|
|
head and neck cancer-- Physiologic Response Imaging in Head and Neck Cancer
|
Clifton Ling
|
|
|
|
health services research-- Patient-Reported Outcomes in Oncology
|
Ethan M. Basch
|
|
|
|
lymphoma and plasma cell disorders-- Prognosis, Risk Stratification, and Treatment of Diffuse Large B-Cell Lymphoma: Incorporation of New Imaging Modalities and Molecular Markers (CPO11A)
|
Andrew David Zelenetz
|
|
|
|
lymphoma and plasma cell disorders-- Prognosis, Risk Stratification, and Treatment of Diffuse Large B-Cell Lymphoma: Incorporation of New Imaging Modalities and Molecular Markers (CPO11B)
|
Andrew David Zelenetz
|
|
|
|
patient and survivor care-- Patient-Reported Outcomes in Oncology
|
Ethan M. Basch
|
|
|
|
patient and survivor care-- Integrating the Humanistic and Scientific Aspects of Patient Care: The Perspective of Seasoned Surgical, Medical, Pediatric, and Radiation Oncologists
|
Teresa Gilewski
|
|
|
|
professional development-- Integrating the Humanistic and Scientific Aspects of Patient Care: The Perspective of Seasoned Surgical, Medical, Pediatric, and Radiation Oncologists
|
Teresa Gilewski
|
|
|
|
sarcoma/bone and soft tissue cancers-- Benefit of Multimodality Management of Advanced Sarcoma: Why the Medical Oncologist Should Not Work Alone
|
Murray F. Brennan
|
|
|
|
tumor biology-- Physiologic Response Imaging in Head and Neck Cancer
|
Clifton Ling
|
|
|
|
meet the professor sessions-- Chemotherapy-Induced Cognitive Impairment (M06)
|
Tim A Ahles
|
|
|
|
clinical problems in oncology-- Prognosis, Risk Stratification, and Treatment of Diffuse Large B-Cell Lymphoma: Incorporation of New Imaging Modalities and Molecular Markers (CPO11A)
|
Andrew David Zelenetz
|
|
|
|
clinical problems in oncology-- Prognosis, Risk Stratification, and Treatment of Diffuse Large B-Cell Lymphoma: Incorporation of New Imaging Modalities and Molecular Markers (CPO11B)
|
Andrew David Zelenetz
|
|
February 19, 2008
|
Screening Europe
|
Track A Novel High-Throughput Platforms
|
Hakim Djaballah
|
|
|
|
Track A High Content Screening of Human ES Cells Using Laser Scanning Confocal Microscopy
|
Hakim Djaballah
|
|
February 3, 2008
|
TGF-ß Family in Homeostasis and Disease
|
Keynote Address
|
Joan Massagué
|
|
|
|
Cancer I
|
Joan Massagué
|
How We Rank